257 related articles for article (PubMed ID: 23483444)
1. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
2. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety.
Noor S; Ismail M; Khan F
Front Pharmacol; 2019; 10():1032. PubMed ID: 31607905
[No Abstract] [Full Text] [Related]
3. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.
Murtaza G; Khan MY; Azhar S; Khan SA; Khan TM
Saudi Pharm J; 2016 Mar; 24(2):220-5. PubMed ID: 27013915
[TBL] [Abstract][Full Text] [Related]
4. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
5. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study.
Ismail M; Aziz S; Noor S; Haider I; Shams F; Haq I; Khadim F; Khan Q; Khan F; Asif M
J Crit Care; 2017 Aug; 40():243-250. PubMed ID: 28458171
[TBL] [Abstract][Full Text] [Related]
7. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
8. Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
Noor S; Ismail M; Ali Z
BMC Pharmacol Toxicol; 2019 Jul; 20(1):45. PubMed ID: 31349877
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of potential drug-drug interactions in patients of internal medicine wards of a tertiary care hospital in India.
Bethi Y; Shewade DG; Dutta TK; Gitanjali B
Eur J Hosp Pharm; 2018 Nov; 25(6):317-321. PubMed ID: 31157049
[TBL] [Abstract][Full Text] [Related]
10. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study.
Zafar R; Rehman IU; Shah Y; Ming LC; Goh HP; Goh KW
PLoS One; 2023; 18(9):e0291417. PubMed ID: 37773947
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy.
Ismail M; Khan S; Khan F; Noor S; Sajid H; Yar S; Rasheed I
BMC Cancer; 2020 Apr; 20(1):335. PubMed ID: 32307008
[TBL] [Abstract][Full Text] [Related]
14. Are patients with a nasally placed feeding tube at risk of potential drug-drug interactions? A multicentre cross-sectional study.
Gimenes FRE; Baysari M; Walter S; Moreira LA; Carvalho REFL; Miasso AI; Faleiros F; Westbrook J
PLoS One; 2019; 14(7):e0220248. PubMed ID: 31365563
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan.
Shakeel F; Aamir M; Khan AF; Khan TN; Khan S
BMC Pharmacol Toxicol; 2018 Dec; 19(1):85. PubMed ID: 30526670
[TBL] [Abstract][Full Text] [Related]
16. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of potential drug-drug interactions in cancer patients at a tertiary care hospital in Pakistan.
Choudary NA; Khan A; Wahid A; Abubakar M; Atif M; Ahmad N
J Oncol Pharm Pract; 2022 Apr; 28(3):618-626. PubMed ID: 35075930
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevancy and determinants of potential drug-drug interactions in chronic kidney disease patients: results from a retrospective analysis.
Saleem A; Masood I; Khan TM
Integr Pharm Res Pract; 2017; 6():71-77. PubMed ID: 29354553
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.
Khan Q; Ismail M; Haider I; Khan F
Int J Clin Pharm; 2017 Dec; 39(6):1256-1264. PubMed ID: 28895028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
